Logo image
O117 : Predictors of clinical response: Results from a large, randomized controlled study with tenofovir disoproxil fumarate (TDF) plus peginterferon alfa-2A (PEG) combination for chronic hepatitis B (CHB)
Journal article   Peer reviewed

O117 : Predictors of clinical response: Results from a large, randomized controlled study with tenofovir disoproxil fumarate (TDF) plus peginterferon alfa-2A (PEG) combination for chronic hepatitis B (CHB)

H.L. Chan, S.H. Ahn, W.L. Chuang, A.J. Hui, F. Tabak, R. Mehta, J. Petersen, C.-M. Lee, X. Ma, F.A. Caruntu, …
Journal of hepatology, v 62, pp S251-S252
Apr 2015

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Industry collaboration
Domestic collaboration
International collaboration
Web of Science research areas
Gastroenterology & Hepatology
Logo image